Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Experiences in implementation and publication of operations research interventions: gaps and a way forward.

Kalibala S, Woelk GB, Gloyd S, Jani N, Kay L, Sarna A, Okal J, Ndwiga C, Haberland N, Sinai I.

J Int AIDS Soc. 2016 Jul 20;19(5 Suppl 4):20842. doi: 10.7448/IAS.19.5.20842.

2.

Clinical trials using the Shang Ring device for male circumcision in Africa: a review.

Barone MA, Li PS, Awori QD, Lee R, Goldstein M.

Transl Androl Urol. 2014 Mar;3(1):113-24. doi: 10.3978/j.issn.2223-4683.2014.01.09. Review.

3.

Genital Tenofovir Concentrations Correlate With Protection Against HIV Infection in the CAPRISA 004 Trial: Importance of Adherence for Microbicide Effectiveness.

Kashuba AD, Gengiah TN, Werner L, Yang KH, White NR, Karim QA, Abdool Karim SS.

J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):264-9. doi: 10.1097/QAI.0000000000000607.

4.

HIV prevention through the lens of behavioral economics.

Linnemayr S.

J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):e61-3. doi: 10.1097/QAI.0000000000000499. No abstract available.

5.

Physicians' perceived barriers to management of sexually transmitted infections in Vietnam.

Do K, Minichiello V, Hussain R, Khan A.

BMC Public Health. 2014 Nov 4;14:1133. doi: 10.1186/1471-2458-14-1133.

6.

The biobehavioral Women's Health CoOp in Pretoria, South Africa: study protocol for a cluster-randomized design.

Wechsberg WM, Zule WA, Ndirangu J, Kline TL, Rodman NF, Doherty IA, Novak SP, van der Horst CM.

BMC Public Health. 2014 Oct 15;14:1074. doi: 10.1186/1471-2458-14-1074.

7.

Clinical Trial Design for HIV Prevention Research: Determining Standards of Prevention.

Dawson L, Zwerski S.

Bioethics. 2015 Jun;29(5):316-23. doi: 10.1111/bioe.12113.

8.
9.
10.
11.

Legal and ethical values in the resolution of research-related disputes: how can IRBS respond to participant complaints?

Underhill K.

J Empir Res Hum Res Ethics. 2014 Feb;9(1):71-82. doi: 10.1525/jer.2014.9.1.71.

12.

Silencing sexually transmitted infections: topical siRNA-based interventions for the prevention of HIV and HSV.

Wheeler LA.

Infect Dis Obstet Gynecol. 2014;2014:125087. doi: 10.1155/2014/125087. Review.

13.

Prevention interventions for human immunodeficiency virus in drug-using women with a history of partner violence.

Stockman JK, Ludwig-Barron N, Hoffman MA, Ulibarri MD, Dyer TV.

Subst Abuse Rehabil. 2012 Feb 1;3(Suppl 1):45-57. doi: 10.2147/SAR.S21293.

14.

Pre-exposure prophylaxis for the prevention of HIV infection in high risk populations: a meta-analysis of randomized controlled trials.

Jiang J, Yang X, Ye L, Zhou B, Ning C, Huang J, Liang B, Zhong X, Huang A, Tao R, Cao C, Chen H, Liang H.

PLoS One. 2014 Feb 3;9(2):e87674. doi: 10.1371/journal.pone.0087674.

15.

Factors associated with psychosocial services in ogun state, Nigeria.

Amoran OE.

J Family Med Prim Care. 2013 Jul;2(3):238-43. doi: 10.4103/2249-4863.120725.

16.

User-identified gel characteristics: a qualitative exploration of perceived product efficacy of topical vaginal microbicides.

Morrow KM, Underhill K, van den Berg JJ, Vargas S, Rosen RK, Katz DF.

Arch Sex Behav. 2014 Oct;43(7):1459-67. doi: 10.1007/s10508-013-0235-5.

17.

Sexual risk trajectories among MSM in the United States: implications for pre-exposure prophylaxis delivery.

Pines HA, Gorbach PM, Weiss RE, Shoptaw S, Landovitz RJ, Javanbakht M, Ostrow DG, Stall RD, Plankey M.

J Acquir Immune Defic Syndr. 2014 Apr 15;65(5):579-86. doi: 10.1097/QAI.0000000000000101.

18.

Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties.

Morrow KM, Fava JL, Rosen RK, Vargas S, Shaw JG, Kojic EM, Kiser PF, Friend DR, Katz DF; Project Link Study Team..

AIDS Res Hum Retroviruses. 2014 Jan;30(1):78-91. doi: 10.1089/AID.2013.0099.

19.

Consistent condom use with regular, paying, and casual male partners and associated factors among men who have sex with men in Tamil Nadu, India: findings from an assessment of a large-scale HIV prevention program.

Ramanathan S, Chakrapani V, Ramakrishnan L, Goswami P, Yadav D, Subramanian T, George B, Paranjape R.

BMC Public Health. 2013 Sep 11;13:827. doi: 10.1186/1471-2458-13-827.

Items per page

Supplemental Content

Support Center